These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 15625985)
1. Complications and risks in hematopoietic stem cell transplant patients. Smith LA; Wright-Kanuth MS Clin Lab Sci; 2001; 14(2):118-24. PubMed ID: 15625985 [TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor. Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917 [TBL] [Abstract][Full Text] [Related]
5. Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection. Mossad S; Kalaycio M; Sobecks R; Pohlman B; Andresen S; Avery R; Rybicki L; Jarvis J; Bolwell B Bone Marrow Transplant; 2005 Feb; 35(4):375-81. PubMed ID: 15640827 [TBL] [Abstract][Full Text] [Related]
6. Managing the toxicity of hematopoietic stem cell transplant. Pallera AM; Schwartzberg LS J Support Oncol; 2004; 2(3):223-37; discussion 237-8, 241, 246-7. PubMed ID: 15328824 [TBL] [Abstract][Full Text] [Related]
7. The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation. Safdar A; Rodriguez G; Ohmagari N; Kontoyiannis DP; Rolston KV; Raad II; Champlin RE Cancer; 2005 Feb; 103(4):731-9. PubMed ID: 15641032 [TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection. Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650 [TBL] [Abstract][Full Text] [Related]
9. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Gratwohl A; Brand R; Frassoni F; Rocha V; Niederwieser D; Reusser P; Einsele H; Cordonnier C; ; Bone Marrow Transplant; 2005 Nov; 36(9):757-69. PubMed ID: 16151426 [TBL] [Abstract][Full Text] [Related]
10. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients. Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290 [TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders. Bittencourt H; Rocha V; Filion A; Ionescu I; Herr AL; Garnier F; Ades L; Esperou H; Devergie A; Ribaud P; Socie G; Gluckman E Bone Marrow Transplant; 2005 Sep; 36(5):431-5. PubMed ID: 15980881 [TBL] [Abstract][Full Text] [Related]
12. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy. Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877 [TBL] [Abstract][Full Text] [Related]
13. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Dvorak CC; Steinbach WJ; Brown JM; Agarwal R Bone Marrow Transplant; 2005 Oct; 36(7):621-9. PubMed ID: 16044133 [TBL] [Abstract][Full Text] [Related]
14. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome. Gil L; Styczynski J; Komarnicki M Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001 [TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications. Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955 [TBL] [Abstract][Full Text] [Related]
16. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005]. Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant. Hale KA; Shaw PJ; Dalla-Pozza L; MacIntyre CR; Isaacs D; Sorrell TC Br J Haematol; 2010 Apr; 149(2):263-72. PubMed ID: 20096013 [TBL] [Abstract][Full Text] [Related]